In 1997 was created Skyline Ventures, which is appeared as VC. The main department of described VC is located in the Palo Alto. The company was established in North America in United States.
Opposing the other organizations, this Skyline Ventures works on 11 percentage points more the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year. When the investment is from Skyline Ventures the average startup value is 10-50 millions dollars. The top activity for fund was in 2006. The increased amount of exits for fund were in 2014. Considering the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations.
Among the various public portfolio startups of the fund, we may underline NovaSys, Calibra Medical, Satiety Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Medical Device, Hospital.
The current fund was established by Eric M Gordon, John Freund. We also calculated 3 valuable employees in our database.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Skyline Ventures, startups are often financed by TVM Capital, SV Health Investors, Intersouth Partners. The meaningful sponsors for the fund in investment in the same round are TVM Capital, Intersouth Partners, InterWest Partners. In the next rounds fund is usually obtained by TVM Capital, Intersouth Partners, Montreux Equity Partners.
Related Funds
Funds with similar focus
Fund Name | Location |
British Robotics Seed Fund | Park City, United States, Utah |
Evolve! | California, San Diego, United States |
FONGIT | Geneva, Geneve, Switzerland |
Headland Ventures | California, San Rafael, United States |
Hinokiya Group | Chiyoda, Japan |
IKEA | Delft, The Netherlands, Zuid-Holland |
Ironstone Group Inc. | California, San Francisco, United States |
Mortoff | - |
Peterson Group | China, Hong Kong, Hong Kong Island |
Questa Capital Management | California, San Francisco, United States |
Sequoia Consulting | California, San Mateo, United States |
Shenzhen AVIC Kaisheng Auto Semiconductor Investment | China, Guangdong, Shenzhen |
SVK Crypto | England, London, United Kingdom |
TRI Cap | Minnesota, United States, Waite Park |
Troopa | Laos, Vientiane Capital, Vientiane Prefecture |
Verde Company BVBA | - |
Zhejiang Hongtu Venture Capital Management | China, Jiaxing, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
CIARRA | 02 Sep 2022 | Foshan, Guangdong, China | |||
Muse Technology | $10M | 08 Nov 2021 | Guangzhou, Guangdong, China | ||
Dicerna Pharmaceuticals | $60M | 31 Jul 2013 | Massachusetts, United States | ||
Genocea Biosciences | $30M | 10 Oct 2012 | Cambridge, Massachusetts, United States | ||
Sutro Biopharma | $16M | 08 May 2012 | South San Francisco, California, United States | ||
Collegium Pharmaceutical | $22M | 15 Feb 2012 | Massachusetts, United States | ||
Proteon Therapeutics | $15M | 12 Aug 2011 | Massachusetts, United States | ||
Genocea Biosciences | $35M | 03 Jan 2011 | Cambridge, Massachusetts, United States | ||
Sutro Biopharma | $36M | 17 Nov 2010 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
CIARRA | 02 Sep 2022 | Foshan, Guangdong, China | |||
Muse Technology | $10M | 08 Nov 2021 | Guangzhou, Guangdong, China | ||
Dicerna Pharmaceuticals | $60M | 31 Jul 2013 | Massachusetts, United States | ||
Genocea Biosciences | $30M | 10 Oct 2012 | Cambridge, Massachusetts, United States | ||
Sutro Biopharma | $16M | 08 May 2012 | South San Francisco, California, United States | ||
Collegium Pharmaceutical | $22M | 15 Feb 2012 | Massachusetts, United States | ||
Proteon Therapeutics | $15M | 12 Aug 2011 | Massachusetts, United States | ||
Genocea Biosciences | $35M | 03 Jan 2011 | Cambridge, Massachusetts, United States | ||
Sutro Biopharma | $36M | 17 Nov 2010 | South San Francisco, California, United States |